Home » Topics » Endocrine/metabolic, BioWorld Science

Endocrine/metabolic, BioWorld Science
RSS

AGE inhibitors reported by Alteon

Feb. 12, 1997

Sparta expands clinical trials of retinoid

Feb. 11, 1997

Sumitomo develops ACAT inhibitors

Feb. 11, 1997

Hypoglycemic/hypolipidemic agents from Kyorin

Feb. 11, 1997

Sankyo develops antidiabetic agents

Feb. 11, 1997

Structure of protease involved in osteoporosis solved

Feb. 10, 1997

Unigene Laboratories reveals bioequivalency results for osteoporosis drug

Feb. 7, 1997

Alza signs licensing agreements for transdermal testesterone products

Feb. 7, 1997

Progress in Bone Care's vitamin D pipeline

Feb. 7, 1997

Nonantiresorptive substituted bisphosphonate disclosed by Gador

Feb. 7, 1997

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...